Financial Times: Pharma warning of Brexit impact to public health emergencies
“U.K. pharma industry leaders have warned of the potential impact of Brexit on Europe’s capacity to respond to a continent-wide public health emergency, as they step up their drive to ensure the sector’s interests are addressed when the next phase of negotiations begins. The Association of the British Pharmaceutical Industry and the BioIndustry Association said that Europe’s ability to manage big public health crises related to the use of medicines, such as the Zika virus, could be at risk if the U.K. were excluded from cross-E.U. incident management planning…” (Neville, 12/12).